Journal Watch - 2017

« Back to Most Recent

  1. Heart Disease? PD is a Good Option

    In a single clinic study, 112 new patients starting PD with or without heart disease were followed for 5 years. More people with heart disease had diabetes (53.3% vs. 31.7%), and they tended to be older. But, there were no differences between groups in hospital admissions, peritonitis, or PD technique failure.

    Read the abstract » | (added 02/08/2017)

    Tags: Peritoneal Dialysis

  2. Autonomy is Key to Choice of PD

    French researchers interviewed 150 patients who began dialysis between 2010 and 2014 from four clinics, and their nephrologists, to see what factors influence the choice of PD. Of those who could do PD or HD, 46.7% preferred PD. The main reason for this preference was having or wanting to have autonomy.

    Read the abstract » | (added 02/08/2017)

    Tags: Peritoneal Dialysis

  3. Low Molecular Weight Heparin Use in Nocturnal HD

    Since people sleep during nocturnal HD, a form of heparin with a longer half-life is needed to keep blood from clotting. Enter low molecular weight heparin (LMWH). A study in Hong Kong* randomized 12 nocturnal HD patients to receive nadroparin or unfractioned heparin for a week—and then switch. The researchers concluded that LMWH was safe and effective, though if treatments are done each night, it is important to monitor for build up of the heparin in the blood.

    Read the abstract » | (added 01/09/2017)

    Tags: Hemodialysis

  4. Early and Late Outcomes in Urgent-start PD

    A single-center, matched-case control study compared 26 urgent start PD patients to 78 who started PD in the standard fashion. Urgent-start PD was linked with more catheter leaks and catheter migration. But, the rates of infection were similar, and urgent-start PD was safe.

    Read the abstract » | (added 01/09/2017)

    Tags:

  5. Peritonitis Predicts Long-term Cardiac Outcomes on PD

    A large study (n=5,707) of PD patients from Brazil has found that just one bout of peritonitis boosts the risk of late cardiovascular death by 22%. Two bouts of peritonitis raised the risk by 78%, three by 181%, and four by 284%.

    Read the abstract » | (added 01/09/2017)

    Tags:

  6. Using PET Results to Screen for Encapsulating Peritoneal Sclerosis (EPS)

    Identifying EPS early is vital to effectively treat this rare but devastating problem. Researchers studied whether the amount of sodium removed from the dialysate (sodium sieving) could predict EPS, in a 20-year study of 161 people. Age at PD start, duration of PD, and sodium sieving were all important predictors.

    Read the abstract » | (added 01/09/2017)

    Tags:

  7. PD Patient Education in Australia

    Clinical PD outcomes in Australia were as much as 10-fold different from one site to another. An effort to standardize PD teaching has begun to improve PD outcomes. Of the 54 PD clinics, 70% completed an online survey about their PD teaching practices—which varied widely in the number of hours and presence of competency assessments.

    Read the abstract » | (added 01/09/2017)

    Tags:

  8. Gender, PD Dose, and Anemia

    Do gender and PD adequacy matter in anemia treatment, wondered researchers? Yes, as it turned out. A two-part study first included 2,180 prevalent PD patients, then followed 88 new PD patients for 3 years, recording data once a year. Regardless of adequacy, women had lower hemoglobin levels than men at every point—even with higher ESA doses.

    Read the abstract » | (added 01/09/2017)

    Tags: